These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 9392429)

  • 21. Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I.
    Musliner TA; Long MD; Forte TM; Nichols AV; Gong EL; Blanche PJ; Krauss RM
    J Lipid Res; 1991 Jun; 32(6):917-33. PubMed ID: 1940624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of scavenger receptor class B type I-mediated selective cholesteryl ester uptake from apoA-I(-/-) high density lipoprotein (HDL) by apolipoprotein A-I requires HDL reorganization by lecithin cholesterol acyltransferase.
    Temel RE; Parks JS; Williams DL
    J Biol Chem; 2003 Feb; 278(7):4792-9. PubMed ID: 12473673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer.
    Calabresi L; Franceschini G; Burkybile A; Jonas A
    Biochem Biophys Res Commun; 1997 Mar; 232(2):345-9. PubMed ID: 9125178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3.
    Walsh A; Ito Y; Breslow JL
    J Biol Chem; 1989 Apr; 264(11):6488-94. PubMed ID: 2495286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of lecithin:cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in lipoprotein-X in vitro.
    O K; Frohlich J
    J Lipid Res; 1995 Nov; 36(11):2344-54. PubMed ID: 8656072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single repeat deletion in ApoA-I blocks cholesterol esterification and results in rapid catabolism of delta6 and wild-type ApoA-I in transgenic mice.
    Sorci-Thomas MG; Thomas M; Curtiss L; Landrum M
    J Biol Chem; 2000 Apr; 275(16):12156-63. PubMed ID: 10766851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers.
    Wang WQ; Moses AS; Francis GA
    Biochemistry; 2001 Mar; 40(12):3666-73. PubMed ID: 11297434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
    Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
    Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.
    Ng DS; Francone OL; Forte TM; Zhang J; Haghpassand M; Rubin EM
    J Biol Chem; 1997 Jun; 272(25):15777-81. PubMed ID: 9188474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice.
    Wang L; Sharifi BG; Pan T; Song L; Yukht A; Shah PK
    J Am Coll Cardiol; 2006 Oct; 48(7):1459-68. PubMed ID: 17010811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice.
    Vaisman BL; Klein HG; Rouis M; Bérard AM; Kindt MR; Talley GD; Meyn SM; Hoyt RF; Marcovina SM; Albers JJ
    J Biol Chem; 1995 May; 270(20):12269-75. PubMed ID: 7744879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities.
    Mero N; Van Tol A; Scheek LM; Van Gent T; Labeur C; Rosseneu M; Taskinen MR
    J Lipid Res; 1998 Jul; 39(7):1493-502. PubMed ID: 9684753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice.
    Franceschini G; Calabresi L; Chiesa G; Parolini C; Sirtori CR; Canavesi M; Bernini F
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1257-62. PubMed ID: 10323777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between low-density lipoprotein size and apolipoprotein A-I-containing particles: the ECTIM study.
    Luc G; Bard JM; Poulain P; Arveiler D; Evans AE; Cambien F; Fruchart JC; Ducimetière P
    Eur J Clin Invest; 1997 Mar; 27(3):242-7. PubMed ID: 9088861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrasting in vivo effects of murine and human apolipoprotein A-II. Role of monomer versus dimer.
    Gong EL; Stoltfus LJ; Brion CM; Murugesh D; Rubin EM
    J Biol Chem; 1996 Mar; 271(11):5984-7. PubMed ID: 8626380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein.
    Gu X; Wu Z; Huang Y; Wagner MA; Baleanu-Gogonea C; Mehl RA; Buffa JA; DiDonato AJ; Hazen LB; Fox PL; Gogonea V; Parks JS; DiDonato JA; Hazen SL
    J Biol Chem; 2016 Mar; 291(12):6386-95. PubMed ID: 26797122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.
    Rached F; Santos RD; Camont L; Miname MH; Lhomme M; Dauteuille C; Lecocq S; Serrano CV; Chapman MJ; Kontush A
    J Lipid Res; 2014 Dec; 55(12):2509-20. PubMed ID: 25341944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins.
    Liang HQ; Rye KA; Barter PJ
    J Lipid Res; 1994 Jul; 35(7):1187-99. PubMed ID: 7964180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.